These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6822328)

  • 1. Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels.
    Dao DY; Hynan LS; Yuan HJ; Sanders C; Balko J; Attar N; Lok AS; Word RA; Lee WM;
    Hepatology; 2012 Mar; 55(3):676-84. PubMed ID: 21987355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.
    Takano S; Omata M; Ohto M; Satomura Y
    Dig Dis Sci; 1994 Jan; 39(1):28-32. PubMed ID: 7506644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-HBc IgM in acute and chronic hepatitis B virus infection].
    Gmelin K; Theilmann L; Hasche G; Will H; Czygan P; Doerr HW; Kommerell B
    Klin Wochenschr; 1984 Sep; 62(17):837-42. PubMed ID: 6482320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.
    Lavarini C; Farci P; Chiaberge E; Veglio V; Giacobbi D; Bedarida G; Susani G; Toti M; Almi P; Caporaso N
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1254-6. PubMed ID: 6416354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.
    Gerlich WH; Uy A; Lambrecht F; Thomssen R
    J Clin Microbiol; 1986 Aug; 24(2):288-93. PubMed ID: 3745425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of IgM antibody to hepatitis B core antigen for the differential diagnosis of acute and chronic hepatitis B virus infection and for the evaluation of the inflammatory activity of type B chronic liver diseases.
    Kiyosawa K; Wada S; Imai Y; Sodeyama T; Tanaka E; Yoda H; Furuta S; Kameko M; Kanai M
    Gastroenterol Jpn; 1986 Dec; 21(6):601-7. PubMed ID: 3569748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis.
    Sherlock S
    Dig Dis Sci; 1986 Sep; 31(9 Suppl):122S-132S. PubMed ID: 2942375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transfusion hepatitis type B: long incubation period and poor prognosis in compromised hosts.
    Inoue K; Konda T; Takashima K; Kuwabara Y; Sasaki H
    Gastroenterol Jpn; 1989 Apr; 24(2):198-204. PubMed ID: 2744336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological responses to HBV infection.
    Fagan EA; Williams R
    Gut; 1986 Jul; 27(7):858-67. PubMed ID: 2426162
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of HBs antigen negative fulminant hepatitis with IgM antibody to hepatitis B core antigen persisting more than seven years.
    Suga M; Shibata K; Kodama T; Arima K; Yamada S; Yachi A
    Gastroenterol Jpn; 1991 Oct; 26(5):661-5. PubMed ID: 1752398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody.
    Machida A; Ohnuma H; Tsuda F; Yoshikawa A; Hoshi Y; Tanaka T; Kishimoto S; Akahane Y; Miyakawa Y; Mayumi M
    J Virol; 1991 Nov; 65(11):6024-30. PubMed ID: 1717713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M hepatitis B core antibody: to titer or not to titer? to use or not to use?
    Gitnick G
    Gastroenterology; 1983 Mar; 84(3):653-5. PubMed ID: 6822334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

  • 15. Viral Hepatitis: a review.
    Neimark S; Rogers AI
    Am J Gastroenterol; 1982 Jun; 77(6):431-5. PubMed ID: 6283881
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis.
    Shimizu M; Ohyama M; Takahashi Y; Udo K; Kojima M; Kametani M; Tsuda F; Takai E; Miyakawa Y; Mayumi M
    Gastroenterology; 1983 Mar; 84(3):604-10. PubMed ID: 6822328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
    Ali HY; Faransawy ZE; Al-Megthab NA
    Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.